You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: August 14, 2024

NEOMYCIN SULFATE AND POLYMYXIN B SULFATE GRAMICIDIN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Neomycin Sulfate And Polymyxin B Sulfate Gramicidin patents expire, and when can generic versions of Neomycin Sulfate And Polymyxin B Sulfate Gramicidin launch?

Neomycin Sulfate And Polymyxin B Sulfate Gramicidin is a drug marketed by Pharmafair and is included in one NDA.

The generic ingredient in NEOMYCIN SULFATE AND POLYMYXIN B SULFATE GRAMICIDIN is gramicidin; neomycin sulfate; polymyxin b sulfate. There are five drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the gramicidin; neomycin sulfate; polymyxin b sulfate profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for NEOMYCIN SULFATE AND POLYMYXIN B SULFATE GRAMICIDIN?
  • What are the global sales for NEOMYCIN SULFATE AND POLYMYXIN B SULFATE GRAMICIDIN?
  • What is Average Wholesale Price for NEOMYCIN SULFATE AND POLYMYXIN B SULFATE GRAMICIDIN?
Summary for NEOMYCIN SULFATE AND POLYMYXIN B SULFATE GRAMICIDIN
Drug patent expirations by year for NEOMYCIN SULFATE AND POLYMYXIN B SULFATE GRAMICIDIN
Recent Clinical Trials for NEOMYCIN SULFATE AND POLYMYXIN B SULFATE GRAMICIDIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Chulalongkorn UniversityPhase 3

See all NEOMYCIN SULFATE AND POLYMYXIN B SULFATE GRAMICIDIN clinical trials

US Patents and Regulatory Information for NEOMYCIN SULFATE AND POLYMYXIN B SULFATE GRAMICIDIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmafair NEOMYCIN SULFATE AND POLYMYXIN B SULFATE GRAMICIDIN gramicidin; neomycin sulfate; polymyxin b sulfate SOLUTION/DROPS;OPHTHALMIC 062383-001 Aug 31, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.